Biofourmis creates AI digital health ‘biomarkers’

Latest articles

The Alliance for Longevity Initiatives – fighting aging

Advancing legislation and policies that aim to increase healthy human lifespan. Longevity is a journey that would be good to imagine we're all taking together;...

Team builds first living robots – that can reproduce

AI-designed Xenobots reveal entirely new form of biological self-replication which could prove promising for regenerative medicine. Birds do it, bees do it... now even living...

Aging in place trailblazer focus – Carewell

Carewell – aiding individuals through their caregiving journey with empathy and knowledge. Over the coming weeks, we will be bringing you extracts from 7 trailblazer...

Humanpeople raising £700k for AI preventative health platform

Digital preventative health platform combines blood, DNA and microbiome testing to power up your healthspan with highly personalised supplements. DISCLOSURE: Longevity.Technology (a brand of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

The Alliance for Longevity Initiatives – fighting aging

Advancing legislation and policies that aim to increase healthy human lifespan. Longevity is a journey that would be good to imagine we're all taking together;...

Team builds first living robots – that can reproduce

AI-designed Xenobots reveal entirely new form of biological self-replication which could prove promising for regenerative medicine. Birds do it, bees do it... now even living...

Aging in place trailblazer focus – Carewell

Carewell – aiding individuals through their caregiving journey with empathy and knowledge. Over the coming weeks, we will be bringing you extracts from 7 trailblazer...

Click the globe for translations.

Biofourmis wearable predicts heart failure 14 days prior to heart attack incident – Apple or Google licensing ahead?

Biofourmis, a Singapore-based Biotechnology company has recently raised $35 million to create digital health ‘biomarkers’ developed with AI technology [1]. The finance round was led by Sequoia India and other backers such as Aviva Ventures and Openspace Ventures [2]. This new funding has created an opportunity for the company to expand and improve its products, mainly their new wearable device called ‘Biotvitals’.

The AI wearable is used as a way to predict and prevent medical events such as heart attacks from happening. The sensor uses patient data to create digital biomarkers that can detect even the smallest changes in health such as an irregular heartbeat. The product was originally aimed at those who have been recently discharged from hospital to aid in recovery and care [3].

Longevity.Technology: Heart failure is a killer; being able to predict and prevent it will save and extend countless lives. Biovitals is a very exciting development and we will be watching to see its ongoing journey.

The TRL score for this Longevity.Technology domain is currently set at: ‘Technology has completed initial trials and demonstrates preliminary safety data.’

The TRL score for the technology addressed in this article is: ‘Technology has completed initial trials and demonstrates preliminary safety data.’

The AI wearable’s most prominent area of work so far resides in cardiac incidents such as detecting heart failures or other cardiac conditions. The advantage of this device is that it can be accessed via a mobile app, making the patient data easily accessible and provides a quick and efficient way to prescribe any necessary medical interventions.

Studies showed that that the wearable was able to predict heart failure 14 days prior to an incident. This platform makes patient care a priority and is an important step in the increasing digitalisation of the healthcare system. The CEO of Biofourmis, Kuldeep Singh Rajput claims the aim of the company is to “predict disease before it happens.” [4]

The ‘Biovitals’ device works in collaboration with other providers and pharmaceutical companies to improve the care of patients and treat chronic conditions. This wearable helps healthcare as it can prevent medical emergency events which are extremely costly to the healthcare system.

The device also allows patients and caregivers to remotely access their own records in real-time. Additionally, Biofourmis uses a variety of networks of medical delivery platforms, so that patients get the drugs they need when they need them.

However, as with many digital health devices the element of privacy and hacking is an important factor to consider as extensive medical data would be collected in one device. Another aspect to reflect on is that the device is meant to be worn 24/7 to collect the necessary data, therefore it must always be on you, which for some would be considered highly inconvenient, and of course there’s battery charging.

The ‘Biovitals’ product is one that promotes Longevity through detecting and preventing the warning signs that could lead to long-term disease and medical incidents further down the line. With the increased funding and expansion of the company Bioformis is one to watch. Currently consisting of a team of 10 people and aiming to grow to the 100s in a move to US, the bigger American market and the promise of bigger future funding rounds puts this company in a great position for potential investment, as it has a predicted value of $1 billion in the next round of funding [5].

[1] https://techcrunch.com/2019/05/21/biofourmis-raises-35m/
[2] https://www.crunchbase.com/organization/biofourmis-pte-ltd#section-funding-rounds
[3] https://bit.ly/2KQLXdH
[4] http://gtltlite.blogspot.com/2019/05/biofourmis-raises-35m-to-develop.html
[5] https://bit.ly/2D6uZlw

Image: Denys Prykhodov / Shutterstock.com

Salvinija Roznyte
Staff Writer Salvinija Roznyte is a writer and journalist based in London. She graduated in 2018 with a Bachelor's degree majoring in Writing and Journalism with a minor in Film Studies. She is interested in the way modern medical technology changes and shapes our world.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

Team builds first living robots – that can reproduce

AI-designed Xenobots reveal entirely new form of biological self-replication which could prove promising for regenerative medicine. Birds do it, bees do it... now even living...

Humanpeople raising £700k for AI preventative health platform

Digital preventative health platform combines blood, DNA and microbiome testing to power up your healthspan with highly personalised supplements. DISCLOSURE: Longevity.Technology (a brand of...

A brain fitbit that can spot Alzheimer’s with up to 94% accuracy

Altoida raising new financing for augmented reality cognitive assessment platform that dramatically improves early detection of Alzheimer’s and other neurodegenerative diseases. Earlier this year, AR-powered...

Insilico starts human trial with AI-discovered drug

First human dosed with AI-discovered novel molecule based on an AI-discovered novel target. Insilico Medicine, an end-to-end artificial intelligence (AI)-driven drug discovery company, has announced that the...

Prescribing exercise – still one of the best ways to beat aging

Local authority leisure provider Everyone Active has reopened its essential exercise referral scheme, by joining forces with EXi, the NHS-approved exercise prescription app and...

    Subscribe to our newsletter